U.S. Industrials Stock News

In late February 2026, Toll Brothers announced several luxury community milestones, including the upcoming Toll Brothers at Audubon in Magnolia, Texas, and the final condo building release at New Talley Station in Decatur, Georgia, alongside other high-end developments across Texas, Nevada, South Carolina, and beyond. These launches, combined with recent industry awards and recognition for design and brand strength, underscore how Toll Brothers is concentrating its pipeline in affluent,...

UWM Holdings has agreed to acquire Two Harbors Investment Corp (NYSE:TWO), creating fresh questions for mortgage and mortgage servicing investors. Management at UWM has offered limited detail on how Two Harbors will be integrated, including capital allocation, portfolio positioning, and leadership roles. Investors are reacting to sparse guidance around timing, financial impact, and operational changes, especially given existing financial pressures at Two Harbors. Two Harbors focuses on...

Earlier this week, Clear Secure reported fourth-quarter and full-year 2025 results showing higher sales year over year, issued first-quarter 2026 revenue guidance of US$242–US$245 million, and announced both a 20% increase in its regular quarterly dividend to US$0.15 per share and a special US$0.20 per-share dividend alongside an expanded share repurchase authorization. The company also highlighted strong free cash flow generation, renewed its multiyear partnership with American Express, and...

If you have been wondering whether Kyndryl Holdings is starting to look like value or a value trap, this article walks through the numbers so you can judge that for yourself. The stock last closed at US$12.33, with returns of 1.4% decline over 7 days, 48.0% decline over 30 days, 51.6% decline year to date and 67.6% decline over 1 year. This naturally raises questions about how the market is currently pricing the business. Recent news around Kyndryl has focused on its position as a standalone...

Mobileye Global (NasdaqGS:MBLY) is adding Elektrobit’s Linux platform to its Mobileye Drive system to support Level 4 autonomous driving. The company recently secured a major U.S. OEM win for its advanced driver assistance systems, expanding its ADAS pipeline. Mobileye signed a SuperVision agreement with Mahindra & Mahindra, positioning itself as a Tier 1 supplier and opening new geographic markets. Mobileye Global, known for its driver assistance and autonomous driving technology, is...

If you are wondering whether Aveanna Healthcare Holdings is still attractively priced after its recent run, you are not alone. This article focuses on what the current share price could imply about value. The stock last closed at US$7.36, with returns of 0.3% over 7 days, a 10.8% decline over 30 days, an 8.9% decline year to date, and a 72.8% gain over the past year, as well as a very large 3 year return of around 4x. Recent coverage has centred on Aveanna's role in home and pediatric...

Why VeriSign Is On Investors’ Radar Today VeriSign (VRSN) is back in focus after a recent pullback, with the share price showing a negative return over the past month and past 3 months while longer term returns remain positive. See our latest analysis for VeriSign. The recent pullback, reflected in a 30 day share price return of 10.08% and a 90 day share price return of 9.54%, contrasts with a 3 year total shareholder return of 15.01% and a 5 year total shareholder return of 19.10%. This...

If you are wondering whether uniQure’s current share price reflects its true worth, this breakdown is designed to help you weigh what you are paying against what you are getting. The stock closed at US$15.63, with returns of a 33.3% decline over 7 days, a 32.1% decline over 30 days, a 33.2% decline year to date, but an 18.9% gain over the past year, which may catch the eye of investors thinking about both risk and recovery potential. Recent news around uniQure has focused on its position in...

LeMaitre Vascular (NasdaqGM:LMAT) reported robust Q4 2025 and full-year 2025 financial results. The company announced a new US$100 million share repurchase program. Management approved a 25% dividend increase for shareholders. LeMaitre Vascular focuses on medical devices for vascular surgeons, so its performance tends to track demand for procedures that treat peripheral vascular disease and related conditions. The combination of strong quarterly and full-year 2025 figures with higher...

Crown Castle Inc. previously declared a quarterly cash dividend of US$1.0625 per common share, payable on March 31, 2026, to shareholders of record on March 13, 2026, while reporting fourth-quarter 2025 FFO that exceeded analyst estimates despite a year-over-year revenue decline. Alongside approving a 2026 restructuring plan and executive incentive program, Crown Castle is moving to sell its fiber business, intending to focus on its tower portfolio, repay debt, and repurchase shares, which...

Senior executives at Vertex Pharmaceuticals (NasdaqGS:VRTX), including the SVP & Chief Accounting Officer and the Executive Vice President & Chief Legal Officer, have recently reported material insider stock sales. The transactions were carried out under regulatory trading plans, signaling fresh internal activity at the company. These insider moves come as Vertex reports financial performance and advances an expanding clinical pipeline. Vertex focuses on therapies for serious diseases, and...

If you are wondering whether Leggett & Platt is attractively priced or a value trap, starting with a clear view of its recent share performance and valuation checks can help bring that picture into focus. The stock last closed at US$11.68, with returns of 6.3% year to date and 30.1% over the past year, set against longer term 3 year and 5 year returns of 62.0% and 69.7% declines. Recent news around Leggett & Platt has mainly centered on its position in bedding and furniture components, and...

Pitney Bowes (NYSE:PBI) has launched a $200 million fixed-income offering. The company recently filed a shelf registration to allow more flexible capital raising. These moves follow leadership changes, business transformation efforts, and substantial share buybacks. Pitney Bowes, known for mailing, shipping, and related services, is in the middle of a broader transformation of its operations and leadership. In that context, the combination of a $200 million fixed-income offering and a fresh...

A senior executive at Annaly Capital Management (NYSE:NLY) has sold company shares, according to a recent regulatory filing. The transaction involves insider ownership of the mortgage real estate investment trust and comes at a time when there is limited company specific news. Annaly Capital Management focuses on investing in mortgage related assets, a segment that is closely linked to interest rate policy, housing finance conditions, and broader credit markets. When an insider at a company...

Definium Therapeutics' lead asset, DT120 ODT, has received FDA Breakthrough Therapy Designation for generalized anxiety disorder. The company is approaching pivotal phase III readouts across multiple late stage trials and has launched a new phase II study in autism spectrum disorder. Definium is also increasing its commercial readiness by expanding leadership and building operational infrastructure as it moves toward a potential launch phase. For investors watching NasdaqGS:DFTX, this...

Earlier this week, OLAPLEX Holdings, Inc. launched No.3PLUS Complete Repair Treatment, a three-minute pre-shampoo product using its patented Bond Building Technology™ and new Damage Defense Cationic Complex, supported by a “Science Never Looked So Good” campaign featuring Chloe Fineman and broad distribution across major retail and online channels. This new treatment extends OLAPLEX’s core bond-repair franchise into a faster, more convenient format, aiming to reinforce its science-led brand...

Why Landstar System Stock Is Back in Focus Landstar System (LSTR) has put out its 2025 10-K, flagging lower revenue and net income tied to softer freight demand and higher insurance costs. The filing also details buybacks, dividends, and a planned sale of its Mexican subsidiary. See our latest analysis for Landstar System. The 10-K arrives after a strong run in the shares, with the 90-day share price return of 24.54% far outpacing the 5.25% total shareholder return over the past year. This...

In recent weeks, Alaska Air Group secured a single operating certificate for Alaska Airlines and Hawaiian Airlines, while analysts highlighted its stronger-than-expected earnings, improved cost control, and operational discipline. This combination of operational progress and favorable analyst commentary has supported a more constructive view of Alaska Air Group’s earnings potential and business resilience, even as the airline industry remains cyclical and exposed to cost and demand...

PDF Solutions (PDFS) is back on radar after the Brown Capital Management Small Company Fund added the stock in Q4 2025, citing its AI-focused analytics and semiconductor supply chain solutions as key attractions. See our latest analysis for PDF Solutions. At a share price of US$33.78, PDF Solutions has seen a 24.65% 90 day share price return and a 50.00% 1 year total shareholder return, suggesting momentum has picked up as investors respond to its AI and semiconductor supply chain story. If...

Twist Bioscience (TWST) is back in focus after announcing a licensing deal with Invenra that brings the B-Body bispecific antibody platform under a co-exclusive arrangement, directly expanding Twist’s antibody discovery service offering. See our latest analysis for Twist Bioscience. The licensing news lands after a strong run, with the latest share price at $46.92, a 30 day share price return of 11.69% and a 90 day share price return of 46.58%. Looking further out, the stock shows a 1 year...

If you are wondering whether Palvella Therapeutics at around US$135 is still offering value after a strong run, this article focuses squarely on what the current price might be implying. The stock has moved sharply recently, with a 57.6% return over the last 7 days, 71.5% over 30 days, and 34.6% year to date, while the 1 year return is very large at close to 7x. These moves sit against a backdrop of heightened interest in Palvella Therapeutics, including investor attention around its listing...

If you are wondering whether SolarEdge Technologies' current share price reflects its true worth, this article will walk you through what the numbers are saying about value today. The stock closed at US$35.40 recently, with a 7 day return of a 6.6% decline, a 30 day return of a 1.1% decline, a 12.9% gain year to date and a 114.7% gain over the past year. These figures are set against much weaker 3 year and 5 year returns of an 89.2% decline and an 85.8% decline. Recent share price moves sit...

MaxLinear (NasdaqGS:MXL) plans to showcase its Sierra RAN radio platform with advanced PIM cancellation technology at MWC Barcelona 2026. The company aims to address deployment challenges for Mobile Network Operators by highlighting its RAN radio capabilities at the event. MaxLinear has appointed Kris Sennesael, an experienced semiconductor industry executive, to its Board of Directors and Audit Committee. MaxLinear focuses on radio access network and connectivity solutions, so the MWC...

PENN Entertainment (NasdaqGS:PENN) has ended a proxy battle with activist investor HG Vora through a cooperation agreement. As part of the deal, three new independent directors are joining the board and the board is being expanded. The governance changes follow PENN's exit from its ESPN Bet partnership and ongoing corporate restructuring efforts. PENN Entertainment, a major US regional casino and online gaming operator, is reworking its boardroom as it reorients around its core land based...